Finance News
-
-
Vice President JD Vance & Industry Leaders at Bitcoin Conference After Partnership Signing to Optimize Cybersecurity Solutions: Bullet Blockchain, Inc
-
Remember Internet Pioneers NetCom Solutions & Network Solutions? Founder Emmit J. McHenry is Now Leading the Emerging Cybersecurity Firm Cycurion
- $3.9M Q1 2025 Revenue Following $39M in Cybersecurity Contracts for Education and Transportation Sectors: Cycurion, Inc
-
$77.8 Million in Revenue Through April 2025, Confirms Full-Year Guidance; Fast-Track to 400 Million Run Rate; $1 Billion Target After Key Acquisition
- Miami, Finance, Medical, Health, Marketing, Banking, Media, Healthcare, Biotech, Stocks, Stock Market, Financial, Nasdaq
$750 Million Market Projected to Reach $3.3 Billion Globally in 2034 for New Drug Application Filed on Preservative-Free IV Ketamine: NRx Pharma, Inc
-
From Robinhood to APT Miner: New Passive Income Opportunities in the Digital Asset Era
- $400 Million Run Rate in 2025 for Global Telcom Leader as a Result of Definitive Fintech Acquisition, Fast-Tracking $1 Billion Growth Plan: IQSTEL Inc
-
150% Increase in Fiscal Q2 Sales vs Previous Year to $750,000; Continuous Record Quarters & Profitability for Homebuilding Product: Innovative Designs
- Miami, Finance, Medical, Health, Marketing, Banking, Media, Healthcare, Biotech, Stocks, Stock Market, Financial, NasdaqCEO Selected to Present at Wall Street Conference on May 21, 2025 for Suicidal Depression / PTSD: NRx Pharmaceuticals, Inc. (Stock Symbol: NRXP)
-
Q1 2025 Revenue Soars 92% to $1.13M on Strategic Acquisitions, Organic Growth & Breakthroughs in AI Drones & Quantum Tech: ZenaTech Stock Symbol: ZENA
- $1B Target by 2027 Amid eSIM, Global Roaming Expansion; $57.6M Q1 Revenue and Market Uplisting, Advancing Toward IQSTEL, Inc. (Stock Symbol: IQST)
- Miami, Finance, Medical, Health, Marketing, Banking, Media, Healthcare, Biotech, Stocks, Stock Market, Financial, Nasdaq$7.8M Financing Boosts NRx's Expansion with Kadima Institute Acquisition for PTSD and Depression Care: NRx Pharmaceuticals, Inc. (Stock Symbol: NRXP)
- Miami, Finance, Medical, Health, Marketing, Banking, Media, Healthcare, Biotech, Stocks, Stock Market, Financial, NasdaqPlan Signed to Purchase Kadima Neuropsychiatry Institute as Clinical Treatment Model and Leading Investigative Site Addressing Suicidal Depression
- Business, Finance, Medical, Health, Marketing, Healthcare, Biotech, Stocks, Stock Market, Financial, Nasdaq
$34 Billion Market in 2025 Advancing to $45 Billion in 2026 for Phase III Development of New Blood Thinner, Less Problematic Than Warfrain: $CVKD
-
$56.7 Million Announced in Q1 2025 with Revenue Growth and Progress Toward NASDAQ Uplisting for AI Marketing Company: IQSTEL, Inc. Stock Symbol: IQSTD
- NASDAQ Uplisting for Higher Market Exposure and Wide Corporate Benefits to AI Boosted Marketing Company On Track Towards $1 Billion Revenue by 2027
- Miami, Finance, Medical, Health, Marketing, Banking, Media, Healthcare, Biotech, Stocks, Stock Market, Financial, Nasdaq$4.3 Million Patent Application Waiver Fee Granted by FDA on New Drug Application Fee for Treatment Addressing Suicidal Depression & PTSD: NRX Pharma
- Miami, Finance, Medical, Health, Marketing, Banking, Media, Healthcare, Biotech, Stocks, Stock Market, Financial, Nasdaq$4.3 Million Waiver Exemption Granted by FDA on New Drug Application Fee for Treatment Addressing Suicidal Depression, PTSD: NRx: Stock Symbol: NRXP
- Miami, Finance, Medical, Health, Marketing, Banking, Media, Healthcare, Biotech, Stocks, Stock Market, Financial, NasdaqLarge Strategic Investment from Global Medical Device Manufacturer to Support Clinics Treating Suicidal Depression and PTSD: NRx: (Stock Symbol: NRXP)
- $283.2 Million; $1.40 Per Share in Revenue Reported for 2024 Fueling Impressive 96% Growth for High Tech AI Boosted Marketing Company: iQSTEL $IQST
Mauro Schnaidman named as Managing Director in Miami, Florida